PKM and colorectal cancer: Exosomes derived from chemoresistant cancer cells can transfer ciRS-122 across the cells and facilitate glycolysis to reduce oxaliplatin sensitivity in chemosensitive cells by inhibiting miR-122 and upregulating PKM2 in colorectal cancer (109).